Aurinia Pharmaceuticals Inc.
AUPHNasdaqCIK 1600620HealthcareFiscal year ends Dec 31
Reports and events: 330 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-10-3008:03 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001600620-26-000074 |
| 2026-08-2621:24 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001104659-26-101785 |
| 2026-08-1916:11 ET | 8-K | 8.01 Other events | 0001600620-26-000066 |
| 2026-08-0608:16 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001600620-26-000062 |
| 2026-08-0608:03 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001600620-26-000059 |
| 2026-06-0418:44 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001214659-26-007175 |
| 2026-06-0416:18 ET | 8-K | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001600620-26-000053 |
| 2026-05-1109:20 ET | 8-K | 2.01 Completion of an acquisition or disposition; 9.01 Financial statements and exhibits | 0001140361-26-020402 |
| 2026-05-0708:23 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001600620-26-000049 |
| 2026-05-0708:22 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001600620-26-000048 |
| 2026-04-2116:31 ET | DEF 14A | Proxy statementPeriod 2026-06-03 | 0001600620-26-000039 |
| 2026-04-0316:56 ET | 8-K | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001600620-26-000035 |
| 2026-03-2516:15 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001214659-26-003784 |
| 2026-03-2308:03 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001600620-26-000026 |
| 2026-03-0317:30 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001214659-26-002769 |
| 2026-02-2606:06 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001600620-26-000017 |
| 2026-02-2606:02 ET | 8-K | 2.02 Results of operations | 0001600620-26-000015 |
| 2025-11-0408:00 ET | 8-K | 2.02 Results of operations | 0001600620-25-000108 |
| 2025-11-0406:06 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001600620-25-000106 |
| 2025-08-1321:40 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001104659-25-077809 |
| 2025-07-3106:10 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0001600620-25-000092 |
| 2025-07-3106:01 ET | 8-K | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0001600620-25-000090 |
| 2025-06-3006:03 ET | 8-K | 8.01 Other events | 0001600620-25-000083 |
| 2025-05-1516:06 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results | 0001600620-25-000057 |
| 2025-05-1206:05 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0001600620-25-000049 |
| 2025-05-1206:02 ET | 8-K | 2.02 Results of operations | 0001600620-25-000047 |
| 2025-04-1716:02 ET | DEF 14A | Proxy statementPeriod 2025-05-15 | 0001600620-25-000032 |
| 2025-03-0417:04 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001214659-25-003856 |
| 2025-02-2706:12 ET | 10-K | Annual reportPeriod 2024-12-31 | 0001600620-25-000011 |
| 2025-02-2706:05 ET | 8-K | 2.02 Results of operations | 0001600620-25-000009 |
| 2024-11-0706:17 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0001600620-24-000108 |
| 2024-11-0706:13 ET | 8-K | 2.02 Results of operations; 2.05 Exit or disposal costs; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001600620-24-000106 |
| 2024-09-1216:10 ET | SC 13D | Ownership report, active investor | 0001214659-24-016381 |
| 2024-09-1216:08 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.03 Amendment to articles or bylaws; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001600620-24-000099 |
| 2024-08-0106:07 ET | 10-Q | Quarterly reportPeriod 2024-06-30 | 0001600620-24-000091 |
| 2024-08-0106:03 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001600620-24-000089 |
| 2024-06-1417:25 ET | 8-K | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001600620-24-000087 |
| 2024-05-0316:08 ET | DEF 14A | Proxy statementPeriod 2024-06-14 | 0001600620-24-000064 |
| 2024-05-0206:07 ET | 10-Q | Quarterly reportPeriod 2024-03-31 | 0001600620-24-000051 |
| 2024-05-0206:03 ET | 8-K | 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001600620-24-000049 |
| 2024-04-2916:14 ET | 10-K/A | Annual report, amendedPeriod 2023-12-31 | 0001600620-24-000041 |
| 2024-03-2017:23 ET | SC 13D/A | Ownership report, active investor, amended | 0001104659-24-036780 |
| 2024-02-2916:10 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001600620-24-000027 |
| 2024-02-1506:16 ET | 10-K | Annual reportPeriod 2023-12-31 | 0001600620-24-000012 |
| 2024-02-1506:06 ET | 8-K | 2.02 Results of operations; 2.05 Exit or disposal costs; 8.01 Other events; 9.01 Financial statements and exhibits | 0001600620-24-000010 |
| 2024-01-0506:02 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001600620-24-000001 |
| 2023-11-0206:05 ET | 10-Q | Quarterly reportPeriod 2023-09-30 | 0001600620-23-000044 |
| 2023-11-0206:01 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001600620-23-000043 |
| 2023-09-2116:06 ET | 8-K | 1.01 Entry into a material agreement; 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001600620-23-000040 |
| 2023-08-2116:11 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001600620-23-000030 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 30, 2026, 08:08 ET. Listed shows no prices and gives no investment advice.